Abstract:Abstract Context With the aging of the population and projected increase in osteoporotic fractures coupled with the declining use of osteoporosis medications, there is a compelling need for new approaches to treat osteoporosis. Given that age-related osteoporosis generally coexists with multiple other comorbidities (e.g., atherosclerosis, diabetes, frailty) that share aging as the leading risk factor, there is growing interest in the “Geroscience Hypothesis,” which posits that manipulation of fundamental aging mechanisms will delay the appearance or severity of multiple chronic diseases because these diseases share aging as the underlying risk factor. In this context, one fundamental aging mechanism that has received considerable attention recently as contributing to multiple age-related morbidities is cellular senescence. This mini-review provides an overview on cellular senescence with a focus on its role in mediating age-related bone loss. Methods This summary is based on the authors’ knowledge of the field supplemented by a PubMed search using the terms “senescence,” “aging,” and “bone.” Results There is compelling evidence from preclinical models and supportive human data demonstrating an increase in senescent cells in the bone microenvironment with aging. These cells produce a proinflammatory secretome that leads to increased bone resorption and decreased bone formation, and approaches that either eliminate senescent cells or impair the production of their proinflammatory secretome have been shown to prevent age-related bone loss in mice. Conclusions Targeting cellular senescence represents a novel therapeutic strategy to prevent not only bone loss but potentially multiple age-related diseases simultaneously.

Cellular senescence in skeletal disease: mechanisms and treatment

The Potential Role and Therapeutic Relevance of Cellular Senescence in Skeletal Pathophysiology.

Cellular Senescence: The Driving Force of Musculoskeletal Diseases

Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics

Skeletal Aging and Osteoporosis: Cellular Senescence and Beyond

Cellular senescence in knee osteoarthritis: molecular mechanisms and therapeutic implications

Targeting Cell Senescence for the Treatment of Age-Related Bone Loss

Cellular Senescence and Inflammaging in the Bone: Pathways, Genetics, Anti-Aging Strategies and Interventions

Regulatory cellular and molecular networks in the bone microenvironment during aging

Exploring cellular senescence in the musculoskeletal system: any insights for biomarkers discovery?

Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis

Targeting Cellular Senescence in Aging and Age-Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies

Cellular Senescence: Mechanisms and Therapeutic Potential

Epigenetic regulations of cellular senescence in osteoporosis

Bone Aging, Cellular Senescence, and Osteoporosis

Cellular senescence: the good, the bad and the unknown

Cellular Senescence in Cardiovascular Diseases: From Pathogenesis to Therapeutic Challenges

Targeting Aging with the Healthy Skeletal System: the Endocrine Role of Bone

Characterization of cellular senescence in aging skeletal muscle

The role of cellular senescence in diabetes mellitus and osteoporosis: molecular pathways and potential interventions

Senescent skeletal cells cross-talk with synovial cells plays a key role in the pathogenesis of osteoarthritis